Sistema Nacional de Investigación (SNI) - Panamá Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2017
NCT03442218
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Sistema Nacional de Investigación de Panamá | Sistema Nacional de Investigación (SNI) - Panamá

Active Ingredients

Drugs in Phase 1 Trials (1)

COVID-19 convalescent plasma (1 trial)

Drugs in Other Trials (1)

chlorhexidine (hibitane) (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2